ConductScience.org, home

Paper333124

Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.

Green S and 5 others. J Natl Cancer Inst, 1977. Cited by 128 papers, by iCite.

Cite this record

ConductScience Library. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. Papers, record 333124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/333124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
128
iCite
Relative citation ratio, by iCite
3.7
iCite
Revised in PubMed
2019-05-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Green SS
2Dobrjansky AA
3Chiasson MAM A
4Carswell EE
5Schwartz MKM K
6Old LJL J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EndotoxinsMajor topic
GlycoproteinsMajor topic
NecrosisMajor topic
Neoplasms, ExperimentalMajor topic
Propionibacterium acnesMajor topic
Animals
Escherichia coli
Female
Kinetics
Mice
Mice, Inbred Strains
Species Specificity

Source PubMed

Download CSV of topics

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.

PMIDTitleJournalYearIn PapersSource
30687005Improvement of Mesenchymal Stem Cell Immunomodulatory Properties by Heat-Killed Propionibacterium acnes via TLR2.Front Mol Neurosci2018https://conductscience.org/library/papers/30687005PubMed
25973430
Modulation of Th1/Th2 immune responses by killed Propionibacterium acnes and its soluble polysaccharide fraction in a type I hypersensitivity murine model: induction of different activation status of antigen-presenting cells.
J Immunol Res2015https://conductscience.org/library/papers/25973430PubMed
22448280Adjuvant effect of killed Propionibacterium acnes on mouse peritoneal B-1 lymphocytes and their early phagocyte differentiation.PLoS One2012https://conductscience.org/library/papers/22448280PubMed
9266265Culture and biological activity of Propionibacterium acnes.Infection1997https://conductscience.org/library/papers/9266265PubMed
8478057Induction of macrophage-mediated production of tumor necrosis factor alpha by an L-form derived from Staphylococcus aureus.Infect Immun1993https://conductscience.org/library/papers/8478057PubMed
8262557Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity.Immunology1993https://conductscience.org/library/papers/8262557PubMed
8129045
Immunological priming attenuates the in vivo pathophysiological response to lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in complete Freund's adjuvant-primed mice and in unprimed mice.
Am J Pathol1994https://conductscience.org/library/papers/8129045PubMed
7358772Early cutback in chemical energy production if the Crocker sarcoma (S180) undergoing haemorrhagic necrosis as a result of endotoxin administration.J Cancer Res Clin Oncol1980https://conductscience.org/library/papers/7358772PubMed
6563942Role of histamine in the antitumour activity of endotoxin.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6563942PubMed
6391657Role of first stimulating agents in the production of tumor necrosis factor.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6391657PubMed
6360852Production of lymphocyte activating factor in vivo.Immunology1983https://conductscience.org/library/papers/6360852PubMed
6216215High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes.Infect Immun1982https://conductscience.org/library/papers/6216215PubMed
6196106Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6196106PubMed
6193516Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6193516PubMed
6186366Endotoxin-induced release of tumour necrosis factor and interferon in vivo is inhibited by prior adrenoceptor blockade.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6186366PubMed
6166564Possible importance of macrophage-derived mediators in acute malaria.Infect Immun1981https://conductscience.org/library/papers/6166564PubMed
3894222Macrophage functions in Biozzi mice.Immunology1985https://conductscience.org/library/papers/3894222PubMed
3891627Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.Infect Immun1985https://conductscience.org/library/papers/3891627PubMed
3888244The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis.Br J Cancer1985https://conductscience.org/library/papers/3888244PubMed
3851690Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs.Cancer Immunol Immunother1985https://conductscience.org/library/papers/3851690PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/333124

GET https://conductscience.org/api/papers/v1/333124/cited_by?page=2